Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.

Ozden MG, Tekin NS, Ilter N, Ankarali H.

Am J Clin Dermatol. 2010;11(1):51-4. doi: 10.2165/11311160-000000000-00000.

PMID:
20000875
2.

Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.

Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A.

Br J Dermatol. 2004 Nov;151(5):1071-5.

PMID:
15541087
3.

Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.

Cicek D, Kandi B, Bakar S, Turgut D.

J Dermatolog Treat. 2009;20(6):344-9. doi: 10.3109/09546630802687349.

PMID:
19954391
4.

Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.

Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, Schultz JC, Katz HI, McCormick CL, Parneix-Spake A.

J Am Acad Dermatol. 2007 Aug;57(2):257-64. Epub 2006 Dec 22.

PMID:
17188780
5.

Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.

Rallis E, Nasiopoulou A, Kouskoukis C, Koumantaki E.

Drugs Exp Clin Res. 2004;30(5-6):191-5.

PMID:
15700745
6.

Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.

Lübbe J, Friedlander SF, Cribier B, Morren MA, García-Díez A, Gelmetti C, Hofmann H, Houwing RH, Kownacki S, Langley RG, Virtanen M, Wolff K, Wisseh S, McGeown C, Abrams B, Schneider D; NOBEL (New Online Based ELidel) Study Group.

Am J Clin Dermatol. 2006;7(2):121-31.

PMID:
16605292
7.

Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials.

Ang-Tiu CU, Meghrajani CF, Maano CC.

Expert Rev Clin Pharmacol. 2012 Jan;5(1):91-7. doi: 10.1586/ecp.11.68. Review.

PMID:
22142161
8.

A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.

Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.

J Dermatolog Treat. 2005 Aug;16(3):142-8.

PMID:
16096179
9.

An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.

de Moraes AP, de Arruda EA, Vitoriano MA, de Moraes Filho MO, Bezerra FA, de Magalhães Holanda E, de Moraes ME.

J Eur Acad Dermatol Venereol. 2007 May;21(5):596-601.

PMID:
17447972
10.
12.

A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.

Karabulut AA, Izol Serel B, Eksioglu HM.

J Eur Acad Dermatol Venereol. 2008 Jun;22(6):729-34. doi: 10.1111/j.1468-3083.2008.02589.x. Epub 2008 Mar 3.

PMID:
18328059
13.
14.

Spotlight on topical pimecrolimus in atopic dermatitis.

Wellington K, Jarvis B.

Am J Clin Dermatol. 2002;3(6):435-8. Review.

PMID:
12113651
15.

Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study.

Braza TJ, DiCarlo JB, Soon SL, McCall CO.

Br J Dermatol. 2003 Jun;148(6):1242-4.

PMID:
12828755
16.

Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: an open-label clinical study in Korean patients.

Kim BS, Kim SH, Kim MB, Oh CK, Jang HS, Kwon KS.

J Korean Med Sci. 2007 Oct;22(5):868-72.

17.

Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.

Jacobi A, Braeutigam M, Mahler V, Schultz E, Hertl M.

Dermatology. 2008;216(2):133-6. doi: 10.1159/000111510. Epub 2008 Jan 23.

PMID:
18216475
18.
19.

A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.

Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.

Br J Dermatol. 2007 Nov;157(5):954-9.

PMID:
17935515
20.

Treatment of seborrheic dermatitis: comparison of sertaconazole 2 % cream versus pimecrolimus 1 % cream.

Goldust M, Rezaee E, Raghifar R.

Ir J Med Sci. 2013 Dec;182(4):703-6. doi: 10.1007/s11845-013-0960-8. Epub 2013 May 29.

PMID:
23715821

Supplemental Content

Support Center